Efficacy of Omalizumab in a Patient with Angioedema Clinically Resembling a Hereditary Angioedema

Detalles Bibliográficos
Autores principales: Kutlu, Ali, Karabacak, Ercan, Aydın, Ersin, Akarsu, Selim, Öztürk, Sami
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Dermatological Association; The Korean Society for Investigative Dermatology 2016
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4884717/
https://www.ncbi.nlm.nih.gov/pubmed/27274639
http://dx.doi.org/10.5021/ad.2016.28.3.381
_version_ 1782434403391111168
author Kutlu, Ali
Karabacak, Ercan
Aydın, Ersin
Akarsu, Selim
Öztürk, Sami
author_facet Kutlu, Ali
Karabacak, Ercan
Aydın, Ersin
Akarsu, Selim
Öztürk, Sami
author_sort Kutlu, Ali
collection PubMed
description
format Online
Article
Text
id pubmed-4884717
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Korean Dermatological Association; The Korean Society for Investigative Dermatology
record_format MEDLINE/PubMed
spelling pubmed-48847172016-06-03 Efficacy of Omalizumab in a Patient with Angioedema Clinically Resembling a Hereditary Angioedema Kutlu, Ali Karabacak, Ercan Aydın, Ersin Akarsu, Selim Öztürk, Sami Ann Dermatol Letter to the Editor Korean Dermatological Association; The Korean Society for Investigative Dermatology 2016-06 2016-05-25 /pmc/articles/PMC4884717/ /pubmed/27274639 http://dx.doi.org/10.5021/ad.2016.28.3.381 Text en Copyright © 2016 The Korean Dermatological Association and The Korean Society for Investigative Dermatology http://creativecommons.org/licenses/by-nc/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Letter to the Editor
Kutlu, Ali
Karabacak, Ercan
Aydın, Ersin
Akarsu, Selim
Öztürk, Sami
Efficacy of Omalizumab in a Patient with Angioedema Clinically Resembling a Hereditary Angioedema
title Efficacy of Omalizumab in a Patient with Angioedema Clinically Resembling a Hereditary Angioedema
title_full Efficacy of Omalizumab in a Patient with Angioedema Clinically Resembling a Hereditary Angioedema
title_fullStr Efficacy of Omalizumab in a Patient with Angioedema Clinically Resembling a Hereditary Angioedema
title_full_unstemmed Efficacy of Omalizumab in a Patient with Angioedema Clinically Resembling a Hereditary Angioedema
title_short Efficacy of Omalizumab in a Patient with Angioedema Clinically Resembling a Hereditary Angioedema
title_sort efficacy of omalizumab in a patient with angioedema clinically resembling a hereditary angioedema
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4884717/
https://www.ncbi.nlm.nih.gov/pubmed/27274639
http://dx.doi.org/10.5021/ad.2016.28.3.381
work_keys_str_mv AT kutluali efficacyofomalizumabinapatientwithangioedemaclinicallyresemblingahereditaryangioedema
AT karabacakercan efficacyofomalizumabinapatientwithangioedemaclinicallyresemblingahereditaryangioedema
AT aydınersin efficacyofomalizumabinapatientwithangioedemaclinicallyresemblingahereditaryangioedema
AT akarsuselim efficacyofomalizumabinapatientwithangioedemaclinicallyresemblingahereditaryangioedema
AT ozturksami efficacyofomalizumabinapatientwithangioedemaclinicallyresemblingahereditaryangioedema

Ejemplares similares